Mast cell tumor epidemiology and demographics: Difference between revisions
No edit summary |
|||
| Line 13: | Line 13: | ||
===Age=== | ===Age=== | ||
*Patients of all age groups may develop mast cell tumor. | *Patients of all age groups may develop mast cell tumor. | ||
* | *[[Urticaria pigmentosa]], the cutaneous mastocytosis is more common in children and the disease manifest itself in the first year of life in over 80% of cases.<ref name="FerranteScavone2015">{{cite journal|last1=Ferrante|first1=Giuliana|last2=Scavone|first2=Valeria|last3=Muscia|first3=Maria|last4=Adrignola|first4=Emilia|last5=Corsello|first5=Giovanni|last6=Passalacqua|first6=Giovanni|last7=La Grutta|first7=Stefania|title=The care pathway for children with urticaria, angioedema, mastocytosis|journal=World Allergy Organization Journal|volume=8|issue=1|year=2015|pages=5|issn=1939-4551|doi=10.1186/s40413-014-0052-x}}</ref> | ||
*Second smaller peak of incidence is observed in adults in the third to fourth decade.<ref name="FerranteScavone2015">{{cite journal|last1=Ferrante|first1=Giuliana|last2=Scavone|first2=Valeria|last3=Muscia|first3=Maria|last4=Adrignola|first4=Emilia|last5=Corsello|first5=Giovanni|last6=Passalacqua|first6=Giovanni|last7=La Grutta|first7=Stefania|title=The care pathway for children with urticaria, angioedema, mastocytosis|journal=World Allergy Organization Journal|volume=8|issue=1|year=2015|pages=5|issn=1939-4551|doi=10.1186/s40413-014-0052-x}}</ref> | *Second smaller peak of incidence is observed in adults in the third to fourth decade.<ref name="FerranteScavone2015">{{cite journal|last1=Ferrante|first1=Giuliana|last2=Scavone|first2=Valeria|last3=Muscia|first3=Maria|last4=Adrignola|first4=Emilia|last5=Corsello|first5=Giovanni|last6=Passalacqua|first6=Giovanni|last7=La Grutta|first7=Stefania|title=The care pathway for children with urticaria, angioedema, mastocytosis|journal=World Allergy Organization Journal|volume=8|issue=1|year=2015|pages=5|issn=1939-4551|doi=10.1186/s40413-014-0052-x}}</ref> | ||
*Systemic mastocytosis generally occurs in middle age. | |||
===Gender=== | ===Gender=== | ||
Revision as of 19:25, 8 March 2016
|
Mast cell tumor Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Mast cell tumor epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Mast cell tumor epidemiology and demographics |
|
Risk calculators and risk factors for Mast cell tumor epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Suveenkrishna Pothuru, M.B,B.S. [2]
Overview
Mast cell tumor is a rare disease and considered to be an "orphan disease" affecting 200,000 or fewer people in the United States. There are no definite data regarding the prevalence of mast cell tumor among the US general population.[1] Cutaneous mastocytosis is more common in children and the disease manifest itself in the first year of life in over 80% of cases.[2] There is no sex predilection and race predilection to the mast cell tumor.
Epidemiology and Demographics
Mast cell tumor is a rare disease characterized by abnormal growth and accumulation of mast cells in various organs.[1] It is considered to be an "orphan disease" affecting 200,000 or fewer people in the United States.
Incidence
- There are no definite data regarding the exact incidence and prevalence of mast cell tumor among the US general population.[3]
Age
- Patients of all age groups may develop mast cell tumor.
- Urticaria pigmentosa, the cutaneous mastocytosis is more common in children and the disease manifest itself in the first year of life in over 80% of cases.[2]
- Second smaller peak of incidence is observed in adults in the third to fourth decade.[2]
- Systemic mastocytosis generally occurs in middle age.
Gender
- There is no sex predilection to the mast cell tumor.
Race
- There is no racial predilection to the mast cell tumor.
References
- ↑ 1.0 1.1 Koenig, Martial; Morel, Jérôme; Reynaud, Jacqueline; Varvat, Cécile; Cathébras, Pascal (2008). "An unusual cause of spontaneous bleeding in the intensive care unit – mastocytosis: a case report". Cases Journal. 1 (1): 100. doi:10.1186/1757-1626-1-100. ISSN 1757-1626.
- ↑ 2.0 2.1 2.2 Ferrante, Giuliana; Scavone, Valeria; Muscia, Maria; Adrignola, Emilia; Corsello, Giovanni; Passalacqua, Giovanni; La Grutta, Stefania (2015). "The care pathway for children with urticaria, angioedema, mastocytosis". World Allergy Organization Journal. 8 (1): 5. doi:10.1186/s40413-014-0052-x. ISSN 1939-4551.
- ↑ Brockow K (2014). "Epidemiology, prognosis, and risk factors in mastocytosis". Immunol Allergy Clin North Am. 34 (2): 283–95. doi:10.1016/j.iac.2014.01.003. PMID 24745674.